Preoperative C-reactive protein is related with renal cell tumor dimension? Preliminary results

Vol. 63 No. 4, 2022


Adelina Miron, Viorel Jinga, George Daniel Radavoi, Tudor Marian Proca, Andreea Stan, Dragos Puia, Catalin Pricop

Introduction: Renal tumors do not benefit from an unanimously accepted tumor marker. We tried to evaluate the advantages of preoperative C-reactive protein (CRP) values and monitor the dynamic of CRP values from the perspective of the evolution of patients diagnosed with Grawitz tumors. Patients, Materials and Methods: We researched the medical records of patients with renal parenchymal tumors admitted to the Urological Clinic in Iasi, Romania, between 01.01.2018 and 01.08.2022. Data were collected regarding age, environment, comorbidities, paraclinical data, tumor characteristics, and treatment performed. Ninety-six patients were included. The data on the inflammatory syndrome pre- and postoperatively were evaluated comparatively. All patients were diagnosed with clear cell renal cell carcinoma (RCC). Results: We found that the renal tumor dimension correlates with an increased preoperative CRP level. For other variables, the correlations regarding age, sex, tumor, node, metastasis (TNM) stage, and size in relation to the increase or decrease of CRP had no statistical significance. Conclusions: The analysis of preoperative CRP and CRP dynamics could predict the tumor s aggressiveness and the treatment s effectiveness. A clear association between CRP levels and RCC pathogenesis is not yet defined, thus, further studies are necessary.

Corresponding author: George Daniel Radavoi, MD, PhD; e-mail:

DOI: 10.47162/RJME.63.4.06 Download PDF
Download cover
Download contents

Journal archive